Children aged 12 and over are now eligible to receive the Moderna mRNA vaccine for immunisation against the CCP virus after Australia’s drug regulator granted provisional approval. The Therapeutic Goods Administration (TGA) said on Sept. 4 the decision had been fast-tracked, with the regulator saying the vaccine met its safety standards for use in Australia. This comes after people aged 18 and over had already granted provisional approval for Moderna’s Spikevax (elasomeran) vaccine on Aug. 9. The recommended Moderna dosage remains the same as for adults, with two doses, 28 days apart. “The Moderna COVID-19 vaccine has shown strong efficacy preventing symptomatic COVID-19 and severe COVID-19 in clinical trials,” the TGA said in a media release on Sept. 4. “The vaccine has also received regulatory approval or authorisation in several countries and is being widely used in the United Kingdom, Canada, the European Union, the United States, Switzerland, and Singapore.” …